- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Societal Cost of Obesity Could Reach $1.1 Trillion
If all 12.7 million US youth with obesity become obese adults, the individual cost on average is just over $92,000, and the societal costs over their lifetimes may exceed $1.1 trillion, according to findings from the Brookings Institute.
"The lifetime costs of obesity are sobering to say the least," said University of California System President Janet Napolitano at an event today to discuss new research that quantifies the economic costs of obesity in the US.
Ms Napolitano—former US secretary of homeland security and former governor of Arizona—addressed findings from the Center on Social and Economic Dynamics at Brookings, in partnership with the World Food Center of the University of California-Davis, that estimate that if all 12.7 million US youth with obesity become obese adults, the individual cost on average is just over $92,000, and "the societal costs over their lifetimes may exceed $1.1 trillion."
Read more at Brookings: http://brook.gs/1AWWlDi
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
